Actuate Therapeutics, Inc. Common stock (ACTU) — Net Asset Momentum
Actuate Therapeutics, Inc. Common stock (ACTU) recorded a net asset momentum of 100.1% as of December 2024, with net assets of $104.19K USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check tangible net worth ratio of Actuate Therapeutics, Inc. Common stock to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Actuate Therapeutics, Inc. Common stock Net Asset Momentum (2022–2024)
This chart tracks Actuate Therapeutics, Inc. Common stock's year-over-year net asset growth across 3 annual reporting periods from 2022 to 2024. The most recent momentum reading is +100.1%, with net assets of $104.19K USD as of December 2024. Read how much debt does Actuate Therapeutics, Inc. Common stock carry for a breakdown of total debt and financial obligations.
Annual Net Asset History for Actuate Therapeutics, Inc. Common stock (2022–2024)
The table below shows the complete annual net asset history for Actuate Therapeutics, Inc. Common stock from 2022 to 2024, covering 3 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Actuate Therapeutics, Inc. Common stock (ACTU) market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $104.19K | $9.32 Million | $9.21 Million | ▲ +100.1% |
| 2023 | $-99.63 Million | $3.00 Million | $102.62 Million | ▼ -771.7% |
| 2022 | $14.83 Million | $20.48 Million | $5.65 Million | — |